Building upon our previous findings that demonstrated OPN's ability to activate the Nrf2 pathway and upregulate downstream antioxidants including HO‐1, the current study focuses on investigating the novel role of the Nrf2‐BDNF axis in mediating OPN's effects on post‐ICH depression [30]. Here, SPP1 is linked to depressive symptom measurement.